View Single Post
Old 08-10-2014, 05:35 AM   #1
Gail
Member
 
Gail's Avatar
 
Join Date: Jan 2014
Posts: 21
Adding Lapatinib to Trastuzumab Does Not Lengthen the Lives of Women with HER2+

Adding Lapatinib to Trastuzumab Does Not Lengthen the Lives of Women with Early-Stage, HER2-Positive Breast Cancer



http://www.cancer.net/es/node/31201
__________________
DX 5th November 2013
Age 49 premenopausal
Lumpectomy (left) 19th November 2013
8mm, Grade 3 IDC,
Stage 1, node negative
ER++ PR+++ Her2+++, Ki67 70 - 80%
BRCA tested - negative
AC chemo began 3rd January 2014 (4 rounds) completed
Paclitaxel weekly for 12 rounds cancelled after round 6 due to neuropathy
Docetaxel began 30th May 2014 - 2 rounds completed 20th June
Herceptin (3 weekly for 1 year) began 11th April 2014
Radio completed 2nd September 2014
Long dates cause I'm an Aussie and will mess up if I try to do it your way :)

Gail is offline   Reply With Quote